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Abstract
Virulence factors are thought to be responsible for the virulence capacity of pathogenic bacteria. However, epidemic bacteria were
recently found to contain signiﬁcantly fewer ‘virulence factors’ than non-epidemic species, and some of the most dangerous epidemic
bacteria, such as Mycobacteria spp. and Rickettsia spp., have reduced genomes, and contain hundreds of degraded genes. Epidemic bacte-
ria are actually highly specialized species, characterized by allopatric speciation, that, after adapting to their hosts, attempt to maintain a
balance between gene gain and gene loss that favours gene loss, ﬁnally leading to genome reduction. Recent comparative genomic stud-
ies have demonstrated that the specialization of bacteria to eukaryotic cells is associated with massive gene loss. Furthermore, the 12
deadliest epidemic species for humankind have signiﬁcantly smaller genomes, with fewer open reading frames, than less dangerous spe-
cies. Epidemic species mostly lose genes related to metabolic activity, the production of energy, cell motility, and transcription. Epidemic
bacteria also possess a damaged recombination and repair system and signiﬁcantly more toxins than closely related non-pathogenic or
non-epidemic species, and more toxin–antitoxin modules. Epidemic bacteria are therefore highly specialized species that are adapted to
their hosts and characterized by extensive genome reduction. Except for toxins and toxin–antitoxin modules, which have a direct and
measurable effect, other ‘virulence factors’ are factors associated with ﬁtness in experimental models. Epidemic species are deﬁned by a
virulent genomic repertoire including both present and absent genes.
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Introduction
Virulence factors are thought to be responsible for the viru-
lence capacity of pathogenic bacteria [1]. This widespread
and anthropocentric idea comes from the fact that deletion
of genes in pathogens has a detrimental effect on their ﬁt-
ness and on their capability to cause disease [2]. Therefore,
these removed genes were referred to as ‘virulence factors’
[3]. However, recent comparative studies have demonstrated
that some of the most dangerous epidemic bacteria, such as
Mycobacterium leprae and Rickettsia prowazekii, whose host
range is extremely restricted, have reduced genomes and
contain hundreds of degraded genes [4–10]. Furthermore,
genes deﬁned as coding for ‘virulence factors’ are also found
in non-pathogenic species [11], and epidemic bacteria were
found to contain signiﬁcantly fewer ‘virulence factors’ than
non-epidemic species [12]. In a study on a group of Escheri-
chia coli strains (B2) involved in commensalism and in intesti-
nal and extraintestinal pathogenesis, genes considered to be
associated with virulence were found to be implicated in
complex host–commensal niche colonization [13], providing
evidence that virulence is a coincidental byproduct of com-
mensalism [14].
If ‘virulence factors’ do not constitute the main character-
istic of highly pathogenic bacteria, then what does? In this
review, I examine recent genomic studies in an effort to
determine the features that characterize the pathogenic
capacity of the most dangerous epidemic bacteria.
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Speciation
The most dangerous epidemic bacteria are specialized for
eukaryotic cells. The notions of allopatry and sympatry are
now used to describe the lifestyle of bacteria [15,16]. Sym-
patric bacteria live in the same environment, or geographical
area, and therefore they exchange genes easily because they
interact with many other bacteria of different phyla. For
example, amoebae and arthropods constitute sympatric envi-
ronments in which bacteria evolve [15,17]. These bacteria
constitute species complexes and not bona ﬁde species, and
they often have the largest genomes, have more genes, are
more resistant to physicochemical agents, and have better
metabolic capacities [11]; they are therefore better adapted
to their environment [18]. New metabolic abilities are gained
by these complexes through horizontal gene transfer (HGT)
[19]. Other events in microbial evolution, such as recombi-
nation, point mutations, and genome rearrangements, allow
better adaptation to new niches without implying genetic iso-
lation boundaries. In a general way, sympatric species create
new genomic repertoires that form the reservoir of future
specialists. Specialization results in allopatry, or geographical
isolation, and a lack of gene acquisition through HGT. Allo-
patric speciation will therefore be characterized by an irre-
versible genomic size restriction. The DNA recombination
and repair system is defective, and the introduction of dele-
terious mutations will lead to further loss of functions of
genes. Deregulation will eventually lead to uncontrolled mul-
tiplication, and pathogenicity is demonstrated by destruction
of the ecosystem. Most dangerous pathogenic epidemic bac-
teria are actually highly specialized species that, after adapting
to their hosts, attempt to maintain a balance between gene
gain and gene loss that favours gene loss, ﬁnally leading to
genome reduction [12].
Gene Loss
Recent comparative genomic studies have demonstrated that
the specialization of bacteria to eukaryotic cells is associated
with massive gene loss [10,20] and the loss of ‘virulence fac-
tors’ [21]. Speciation is accompanied by a reduced number
of ribosomal operons [22] and by the loss of 100 genes by
all obligate intracellular bacteria, suggesting an irreversible
association with the host [10]. In a study on the evolution of
the Rickettsiales, it was demonstrated that evolution from a
free-living lifestyle to an obligate intracellular one was associ-
ated with the loss of 2135 genes [23]. Furthermore, the 12
deadliest epidemic species for humankind have signiﬁcantly
smaller genomes, with fewer open reading frames, than less
dangerous species [12].
One of the best examples of genomic reduction of epi-
demic bacteria is R. prowazekii, the agent of epidemic typhus.
No virulence genes have been identiﬁed in its genome, and
24% of its small genome is composed of pseudogenes and
non-coding DNA [24,25]. Intracellular motility, which has
been considered to be a virulence factor for Listeria monocyt-
ogenes [26] and Shigella [15], is not found in R. prowazekii,
which is completely immobile in the cytoplasm [27,28].
Genes coding for amino acid biosynthesis are lost from
R. prowazekii, as are translation regulation factors; translation
capacities are decreased [24]. In another study comparing
Rickettsia africae with Rickettsia rickettsii, it was demonstrated
that the loss of essential genes was a key factor involved in
the development of pathogenicity [9].
Other examples of excessive gene loss in epidemic patho-
gens are provided by Mycobacteria spp. and, especially, M. le-
prae, which has the largest proportion of non-coding DNA
[5]; only 49.5% of its genome contains protein-coding genes.
The leprosy bacillus has lost about 2000 genes, including
genes involved in biosynthetic pathways [29]. Studies on
Mycobacterium tuberculosis have shown that deletion of genes
confers a hypervirulent phenotype [30], and Mycobacterium
ulcerans has become specialized with the loss of ‘virulence
factors’ and immunogenes [31].
Another paradigm of gene loss occurred during the evolu-
tion of two other host-restricted species, Bordetella pertussis
and Bordetella parapertussis. Metabolic pathways and regula-
tory networks were modiﬁed, resulting in virulence charac-
teristics and effective host infection [32].
Finally, an outstanding example of a dangerous epidemic
pathogen is Shigella dysenteriae. It is a clone from the E. coli
complex that differs from E. coli in its poor phenotypic traits
(extracellular immobility and inability to ferment lactose)
[33,34]. The most plausible scenario is that Shigella evolved
from the E. coli complex through a plasmid containing critical
genes. Then, massive gene deletions followed that increased
its virulence, and virulence genes were lost, as in other path-
ogenic bacteria [35]. A recent comparative genomic study
demonstrated that generally, ten of 23 functional COG cate-
gories contain signiﬁcantly fewer genes in the deadliest epi-
demic bacteria. These categories contain genes mostly
related to metabolic activity, the production of energy, cell
motility, and transcription. The most dangerous epidemic
bacteria also possess a damaged recombination and repair
system, and present an accumulation of poly(A) tails. These
tails lead to an accumulation of stop codons and to gene
degradation. Because the repair machinery of epidemic bac-
teria is deﬁcient, polymerase errors will not be corrected,
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and genes will be inactivated, eventually resulting in pseudog-
enization and total gene loss [12]. Epidemic pathogens are
therefore deregulated and evidently not better armed than
other bacteria.
In summary, a pathogenic species is not characterized by
any virulence factors, except for toxins and toxin–antitoxin
(TA) modules, as we will see below, but by extensive gen-
ome reduction resulting from extreme specialization and
adaptation in a stable environment. In the pathogenic gene
repertoire of most dangerous pathogenic bacteria, absent
genes are as important as those that are present.
Toxins
Toxins are macromolecular substances that, when produced
during infection, or when introduced into an organism, cause
an impairment of physiological functions that leads to disease
or even to the death of the infected organism [36]. Since
1888, toxins have been considered to be the ultimate viru-
lence factors. They are classiﬁed in two categories: bacterial
protein toxins, or exotoxins, and toxic lipopolysaccharide
(LPS) complexes, or endotoxins. Exotoxins are secreted by
living bacteria, and their production is usually speciﬁc to a
particular bacterial species; the disease is associated with the
toxin. The major symptoms associated with diseases caused
by Corynebacterium diphtheriae, B. pertussis, Vibrio cholerae,
Bacillus anthracis and Clostridium botulinicum are related to the
activities of the toxins produced by these organisms [36].
Protein toxins have a chemical, direct and quantiﬁable action
that establishes an aggressive strategy during microbial path-
ogenesis. In contrast, LPS complexes have non-speciﬁc
actions that subvert the host’s immune response, and they
are liberated in the cytoplasm in the case of, for example,
bacterial lysis [37]. In experimental models, LPS complexes
act in a way that does not reﬂect bacterial virulence [38].
This is the reason why the virulence of species such as Sal-
monella and Yersinia, which do not liberate protein toxins,
could not be explained.
In a comparative genomic study on the 14 deadliest epi-
demic bacteria of all times for humankind, all of the epidemic
pathogens were found to have signiﬁcantly smaller genomes
than closely related non-pathogenic or non-epidemic species,
clearly demonstrating extensive gene loss in these species;
the only features found in signiﬁcantly larger numbers in epi-
demic species were TA modules and toxins. Moreover, en-
dotoxins appear to be more related to the pathogenic
capacity of epidemic bacteria than exotoxins [39]. Therefore,
the only proteins that could be considered to be playing a
role as virulence factors are toxins.
TA Modules
TA modules were initially identiﬁed as plasmid stabilization fac-
tors, and it has also been proposed that they play a role in the
control of protein expression [40–42]. These systems are
described as addiction molecules; the toxin and antitoxin
genes are found next to each other on the same operon, so
any effort to eliminate one of the two will lead to the death of
the bacterium. Therefore, these genes are not essential genes,
but genes from which organisms simply cannot be separated
[43]. In our comparative genomic study on the 14 deadliest
bacterial species, we found that epidemic species contained
signiﬁcantly more TA modules than non-epidemic species
[12,39]. These modules are found in epidemic species probably
as a result of HGT from other bacteria that occurred before
specialization of the epidemic species [39]. Previous studies
also reported a high number of TA modules in epidemic spe-
cies, such as Yersinia pestis [44], but their role in pathogenicity
was not considered. Indeed, their role in the virulence capacity
of bacteria is not clearly established yet; however, in a recent
study in our laboratory, it was demonstrated that liberation of
the toxin into the cytoplasm of infected cells can cause death
of the cells by apoptosis [45], and after attempts to limit their
translation, pathogenicity was initiated.
As in the case of endotoxins, TA modules have not previ-
ously been considered to be essential factors in the pathogenic
capacity of epidemic bacteria, because they do not have a
direct effect, like protein toxins. Recent evidence, however,
allows us to consider them as pathogens’ hidden defence
weapons. We could therefore speculate that, in a general way,
epidemic bacteria are not armed to kill; they do not have sup-
plementary virulence factors, except for selﬁsh elements that
express toxicity when the bacterium is threatened.
Discussion
Bacterial species constitute melting pots from which special-
ized species arise regularly [46–48]. Non-specialized species
constitute ‘pre-species’ found in a community that allows
them to exchange genes. At some point, probably because of
an ecological change, they will be specialized to a speciﬁc
niche, and gene exchange will decrease. This specialization
will lead to gene loss and deregulation. Most dangerous path-
ogenic bacteria are therefore highly specialized species,
adapted to their hosts and characterized by extensive gen-
ome reduction [12]. It is becoming increasingly evident that
the pathogenic capacity of bacteria is not the result of ‘viru-
lence factors’ (Fig. 1). Except for TA modules and toxins,
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which have a direct and measurable effect, other ‘virulence
factors’ are factors associated with ﬁtness in experimental
models. Epidemic bacteria have much smaller genomes than
other bacteria, they lack metabolic activity, they are com-
pletely deregulated, with deﬁcient repair machineries, and
they possess toxins, alone or coupled as TA modules [39]
(Table 1). We conclude that epidemic species are deﬁned by
a virulent genomic repertoire including both present and
absent genes. The capacity of epidemic species to obtain
new characteristics is limited because of their genetic isola-
tion. Therefore, any signiﬁcant change in their ecosystem
may result in the disappearance of the bacterium [49]. This
is why we believe that current epidemic pathogens will prob-
ably disappear, but that they will be replaced by other bacte-
ria already in contact with us, emerging from human
commensals, animals, and the environment [50]. Indeed, the
outbreak of bloody diarrhoea and the haemolytic–uraemic
syndrome caused by an E. coli O104:H4 strain in Germany in
May and June 2011 [51] illustrates the capacity of bacterial
species to produce new combinations of genes, leading to
the emergence of highly aggressive strains.
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